Skip to main content

Injectable Small Molecules

Cell and gene therapies and biopharmaceuticals justifiably capture attention for their immense potential to transform human health. But did you know that in 2023, 62% of FDA-approved drugs were small molecules? In fact, 34 of the 55 new drug approvals fell into this category.

Whether you're manufacturing traditional small molecule therapeutics, vaccines, or GLP-1 derivatives, bioMérieux is your trusted partner in prioritizing product and patient safety.

Peace of Mind for What Matters

We can help you stay compliant with regulatory guidelines, enabling you to confidently deliver life-changing medicines to those in need — efficiently and sustainably.

   

   

Our Product Offering For Injectable Small Molecule Quality Control Testing

    

Contact Our Experts

Fill out the short form below and a member of our team will be in touch to discuss your current testing process and how we can partner together to optimize your workflow.